EUVIMEDEUVIMED entdecken
Editorial

Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy

Henver S Brunetta iD

Acta Physiologica · 2026-04 · 242 (4)

DOI: 10.1111/apha.70196 ↗

Kurz gefasst

Editorial in der Zeitschrift Acta Physiologica, online erschienen am 17.03.2026. Verfasst von Henver S Brunetta. Beteiligte Einrichtung: Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.

ORCID-Profile: Henver S Brunetta

Zitieren

APA

Brunetta, H. S. (2026). Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy. Acta Physiologica, 242(4). https://doi.org/10.1111/apha.70196

Vancouver

Brunetta HS. Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy. Acta Physiologica. 2026;242(4). doi:10.1111/apha.70196

BibTeX
@article{Brunetta2026,
  author = {Brunetta, Henver S},
  title = {Hexosamine Pathway as a Therapeutic Strategy in Primary Mitochondrial Encephalopathy},
  journal = {Acta Physiologica},
  year = {2026},
  volume = {242},
  number = {4},
  doi = {10.1111/apha.70196}
}
Kostenlos starten →